MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Non-Current Assets (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Non-Current Assets came in at $152.7 million in Q4 2025, up 4.4% YoY from $146.2 million in Q4 2024, and down 1.69% on a QoQ basis from $155.3 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Non-Current Assets (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Non-Current Assets data on file, last reported at $152.7 million in Q4 2025.

  • Quarterly Non-Current Assets rose 4.4% year-over-year to $152.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $603.7 million (down 3.01% YoY) and the FY2025 annual result came in at $152.7 million, up 4.4% from the prior year.
  • Non-Current Assets fell to $152.7 million in Q4 2025, from $155.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $167.1 million in Q4 2023 to a low of -$228.4 million in Q1 2021.
  • A 5-year average of $30.7 million and a median of $145.2 million in 2024 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Non-Current Assets slumped 45.22% — and 2024, when it surged 235.17%.
  • Tracing MGTX's Non-Current Assets over 5 years: stood at $136.9 million in 2021, then climbed by 19.7% to $163.9 million in 2022, then grew by 1.97% to $167.1 million in 2023, then slipped by 12.5% to $146.2 million in 2024, then gained by 4.4% to $152.7 million in 2025.
  • The last three Non-Current Assets figures came in at $152.7 million (Q4 2025), $155.3 million (Q3 2025), and $151.6 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.15 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 294.93 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.96 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 938.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 18.06 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 468.65 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -215.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -215.08 Mn
Dec 31, 2025 152.67 Mn
Sep 30, 2025 155.30 Mn
Jun 30, 2025 151.63 Mn
Mar 31, 2025 144.13 Mn
Dec 31, 2024 146.23 Mn
Sep 30, 2024 160.44 Mn
Jun 30, 2024 155.88 Mn
Mar 31, 2024 159.94 Mn
Dec 31, 2023 167.12 Mn
Sep 30, 2023 163.66 Mn
Jun 30, 2023 -140.76 Mn
Mar 31, 2023 166.66 Mn
Dec 31, 2022 163.90 Mn
Sep 30, 2022 -147.44 Mn
Jun 30, 2022 -96.93 Mn
Mar 31, 2022 -134.36 Mn
Dec 31, 2021 -176.07 Mn
Sep 30, 2021 -172.90 Mn
Jun 30, 2021 -203.86 Mn